Jiangsu Jibeier Pharmaceutical Co., Ltd. (SHA:688566)

SHA:688566 Revenue

Jiangsu Jibeier Pharmaceutical had revenue of 285.17M CNY in the quarter ending September 30, 2026, with 14.29% growth. This brings the company's total for the last twelve months to 1.04B, up 8.21% year-over-year. In the year 2025, Jiangsu Jibeier Pharmaceutical had annual revenue of 966.07M with 7.76% growth. That makes Jiangsu Jibeier Pharmaceutical the 19,346th largest company in the world by revenue and 3,546th in China.

• Revenue (ttm): 1.04B
• Revenue Growth: +8.21%
• P/S Ratio: 5.06
• Revenue / Employee: 765.40K
• Employees: 1,380
• Market Cap: 5.25B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	966.07M	69.53M	7.76%
Dec 31, 2024	896.53M	35.60M	4.14%
Dec 31, 2023	860.93M	206.20M	31.49%
Dec 31, 2022	654.73M	145.04M	28.46%
Dec 31, 2021	509.69M	-56.28M	-9.94%

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 10, 2026

Data Sources Report a data error